跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利倍卓 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sodium Zirconium Cyclosilicate Powder
Approved
化学药品
Sodium Zirconium Cyclosilicate Powder
ASTRAZENECA AB
🇨🇳 National Medical Products Administration
Approval Date
Dec 30, 2019
Approval ID
7uciuyVpqoh
Company
ASTRAZENECA AB
Type
化学药品
Approval Details
Approval Id
7uciuyVpqoh
Approval Number
H20190072
Generic Name
环硅酸锆钠散
Generic Name En
Sodium Zirconium Cyclosilicate Powder
Trade Name
利倍卓
Brand Name
利倍卓
Drug Type
化学药品
Dosage Form
散剂
Strength
5g
Reg Date
2019-12-30
Expired Date
2024-12-29
Company Name
ASTRAZENECA AB
Company Address
SE-151 85 Sodertalje, Sweden
Production Company Name
AndersonBrecon, Inc.
Production Company Address
4545 Assembly Drive, Rockford, Illinois, 61109, USA
Company Detail Path
/organization/astrazeneca-ab
Production Company Detail Path
/organization/andersonbrecon-inc-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 30, 2019
Approval ID
7uciuyVpqoh
Type
化学药品
Back to NMPA Approvals